EU approves AZ’ biologic Fasenra for severe asthma

11th January 2018 Uncategorised 0

AstraZeneca’s biologic Fasenra has been approved for use in Europe as an add-on maintenance treatment in patients with severe eosinophilic asthma.

More: EU approves AZ’ biologic Fasenra for severe asthma
Source: News